USC study finds unexpected mechanism of cancer metastasis

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Researchers from the Keck School of Medicine of USC discovered that when cells are under stress, a key protein can travel to the nucleus and reprogram cells to migrate and become more invasive.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Detailed positive results from the DESTINY-Breast06 phase III trial showed that Enhertu (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival compared to standard-of-care chemotherapy in patients with HR-positive, HER2-low metastatic breast cancer and the overall trial population (patients with HR-positive, HER2-low and HER2-ultralow [defined as IHC 0 with membrane staining] expression) following one or more lines of endocrine therapy. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login